1George V. Papatheodoridis.Why do I treat HBeAg‐negative chronic hepatitis B patients with nucleos(t)ide analogues?[J]. Liver Int . 2013
2E. Cholongitas,G.V. Papatheodoridis.High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review[J]. American Journal of Transplantation . 2012 (2)
3E. Chaib,B. G. M. M. Coimbra,F. H. F. Galv?o,E. R. Tatebe,M. S. Shinzato,L. A. C D’Albuquerque,E. Massad.Does anti‐hepatitis B virus vaccine make any difference in long‐term number of liver transplantation?[J]. Clin Transplant . 2012 (6)
4Cheng-Yuan Peng,Rong-Nan Chien,Yun-Fan Liaw.Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy[J]. Journal of Hepatology . 2012 (2)
5European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1)
6Patrick Marcellin,Edward Gane,Maria Buti,Nezam Afdhal,William Sievert,Ira M Jacobson,Mary Kay Washington,George Germanidis,John F Flaherty,Raul Aguilar Schall,Jeffrey D Bornstein,Kathryn M Kitrinos,G Mani Subramanian,John G McHutchison,E Jenny Heathcote.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study[J]. The Lancet . 2012
7E. Cholongitas,T. Vasiliadis,N. Antoniadis,I. Goulis,V. Papanikolaou,E. Akriviadis.Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation[J]. Transpl Infect Dis . 2012 (5)
8Alyson N. Fox,Norah A. Terrault.The option of HBIG-free prophylaxis against recurrent HBV[J]. Journal of Hepatology . 2012 (5)
9X.Zhao,W. H.Chong,T.Jake Liang,J. H.Hoofnagle.Renal tubular dysfunction during long‐term adefovir or tenofovir therapy in chronic hepatitis B[J]. Aliment Pharmacol Ther . 2012 (11)
10H. L.Y. Chan,Y. C. Chen,E. J. Gane,S. K. Sarin,D. J. Suh,T. Piratvisuth,B. Prabhakar,S. G. Hwang,G. Choudhuri,R. Safadi,T. Tanwandee,A. Chutaputti,C. Yurdaydin,W. Bao,C. Avila,A. Trylesinski.Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment‐na?ve patients with HBV‐related decompensated cirrhosis[J]. Journal of Viral Hepatitis . 2012 (10)
